IFNGR2 and melanoma: Our ligand-receptor-based cell communication analysis demonstrated increased interactions between ETV4-low melanoma cells and T cells, including TNFSF14-LTBR and IFNG-(IFNGR1+IFNGR2) signaling pathways.